Logo image of RR

RICHTECH ROBOTICS INC-CL B (RR) Stock Fundamental Analysis

NASDAQ:RR - US7655041058 - Common Stock

2.53 USD
-0.01 (-0.39%)
Last: 9/5/2025, 8:00:02 PM
2.4999 USD
-0.03 (-1.19%)
After Hours: 9/5/2025, 8:00:02 PM
Fundamental Rating

3

RR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for RR as it has an excellent financial health rating, but there are worries on the profitability. RR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RR had negative earnings in the past year.
RR had a negative operating cash flow in the past year.
RR Yearly Net Income VS EBIT VS OCF VS FCFRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of RR (-14.08%) is worse than 82.95% of its industry peers.
RR's Return On Equity of -14.25% is on the low side compared to the rest of the industry. RR is outperformed by 76.74% of its industry peers.
Industry RankSector Rank
ROA -14.08%
ROE -14.25%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RR Yearly ROA, ROE, ROICRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

RR has a better Gross Margin (76.08%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of RR has grown nicely.
RR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
RR Yearly Profit, Operating, Gross MarginsRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

RR does not have a ROIC to compare to the WACC, probably because it is not profitable.
RR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, RR has an improved debt to assets ratio.
RR Yearly Shares OutstandingRR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
RR Yearly Total Debt VS Total AssetsRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 175.29 indicates that RR is not in any danger for bankruptcy at the moment.
The Altman-Z score of RR (175.29) is better than 100.00% of its industry peers.
RR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 175.29
ROIC/WACCN/A
WACC9.93%
RR Yearly LT Debt VS Equity VS FCFRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 120.23 indicates that RR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 120.23, RR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RR has a Quick Ratio of 118.23. This indicates that RR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 118.23, RR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 120.23
Quick Ratio 118.23
RR Yearly Current Assets VS Current LiabilitesRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for RR have decreased strongly by -269.66% in the last year.
Looking at the last year, RR shows a very negative growth in Revenue. The Revenue has decreased by -54.70% in the last year.
Measured over the past years, RR shows a very negative growth in Revenue. The Revenue has been decreasing by -11.08% on average per year.
EPS 1Y (TTM)-269.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.77%
Revenue 1Y (TTM)-54.7%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%-18.43%

3.2 Future

Based on estimates for the next years, RR will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.53% on average per year.
The Revenue is expected to grow by 45.78% on average over the next years. This is a very strong growth
EPS Next Y-26.83%
EPS Next 2Y6.99%
EPS Next 3Y12.53%
EPS Next 5YN/A
Revenue Next Year20.24%
Revenue Next 2Y66.36%
Revenue Next 3Y63.53%
Revenue Next 5Y45.78%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RR Yearly Revenue VS EstimatesRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M
RR Yearly EPS VS EstimatesRR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RR Price Earnings VS Forward Price EarningsRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RR Per share dataRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as RR's earnings are expected to grow with 12.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.99%
EPS Next 3Y12.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RICHTECH ROBOTICS INC-CL B

NASDAQ:RR (9/5/2025, 8:00:02 PM)

After market: 2.4999 -0.03 (-1.19%)

2.53

-0.01 (-0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.77%
Inst Owner Change88.02%
Ins Owners1.69%
Ins Owner Change-9.36%
Market Cap379.22M
Analysts80
Price Target3.06 (20.95%)
Short Float %13.59%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-25.19%
Min Revenue beat(2)-31.11%
Max Revenue beat(2)-19.27%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.25%
PT rev (3m)N/A
EPS NQ rev (1m)8.32%
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.51%
EPS NY rev (3m)-14.66%
Revenue NQ rev (1m)-24.72%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-12.15%
Revenue NY rev (3m)-31.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 91.91
P/FCF N/A
P/OCF N/A
P/B 3.58
P/tB 4.01
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0.03
BVpS0.71
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.08%
ROE -14.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.08%
FCFM N/A
ROA(3y)-12.12%
ROA(5y)N/A
ROE(3y)-14.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.85%
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 120.23
Quick Ratio 118.23
Altman-Z 175.29
F-Score5
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.77%
EPS Next Y-26.83%
EPS Next 2Y6.99%
EPS Next 3Y12.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-54.7%
Revenue growth 3Y-11.08%
Revenue growth 5YN/A
Sales Q2Q%-18.43%
Revenue Next Year20.24%
Revenue Next 2Y66.36%
Revenue Next 3Y63.53%
Revenue Next 5Y45.78%
EBIT growth 1Y-1134.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-137.35%
EBIT Next 3Y4.93%
EBIT Next 5YN/A
FCF growth 1Y-837.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-425.5%
OCF growth 3YN/A
OCF growth 5YN/A